Ebarola, Bonifacia R.

HRN: 08-99-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
METRONIDAZOLE 500MG (TAB)
08/03/2022
08/10/2022
ORAL
500mg
TID
SP Explore Lap
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft TissueIntra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: